303 related articles for article (PubMed ID: 25376296)
1. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
Kim H; Park YN
Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
[TBL] [Abstract][Full Text] [Related]
2. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
3. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
[TBL] [Abstract][Full Text] [Related]
5. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
[TBL] [Abstract][Full Text] [Related]
6. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
Chan AW; Tong JH; Chan SL; Lai PB; To KF
Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
[TBL] [Abstract][Full Text] [Related]
7. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.
Govaere O; Komuta M; Berkers J; Spee B; Janssen C; de Luca F; Katoonizadeh A; Wouters J; van Kempen LC; Durnez A; Verslype C; De Kock J; Rogiers V; van Grunsven LA; Topal B; Pirenne J; Vankelecom H; Nevens F; van den Oord J; Pinzani M; Roskams T
Gut; 2014 Apr; 63(4):674-85. PubMed ID: 23958557
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.
Kim GJ; Kim H; Park YN
PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533
[TBL] [Abstract][Full Text] [Related]
9. Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.
Rhee H; Nahm JH; Kim H; Choi GH; Yoo JE; Lee HS; Koh MJ; Park YN
Mod Pathol; 2016 Sep; 29(9):1038-49. PubMed ID: 27312064
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
[TBL] [Abstract][Full Text] [Related]
11. Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.
Zhang Q; Zhang CS; Xin Q; Ma Z; Liu GQ; Liu BB; Wang FM; Gao YT; Du Z
World J Gastroenterol; 2014 Aug; 20(31):10908-15. PubMed ID: 25152593
[TBL] [Abstract][Full Text] [Related]
12. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis.
Ma YC; Yang JY; Yan LN
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1007-16. PubMed ID: 23478672
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
Jiang S; Pei L; Yang ZL; Liu G
Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
[TBL] [Abstract][Full Text] [Related]
14. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
[No Abstract] [Full Text] [Related]
15. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.
Guo Z; Li LQ; Jiang JH; Ou C; Zeng LX; Xiang BD
World J Gastroenterol; 2014 Feb; 20(8):2098-106. PubMed ID: 24616575
[TBL] [Abstract][Full Text] [Related]
17. Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.
Zen C; Zen Y; Mitry RR; Corbeil D; Karbanová J; O'Grady J; Karani J; Kane P; Heaton N; Portmann BC; Quaglia A
Liver Transpl; 2011 Aug; 17(8):943-54. PubMed ID: 21491582
[TBL] [Abstract][Full Text] [Related]
18. Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression.
Rhee H; Chung T; Yoo JE; Nahm JH; Woo HY; Choi GH; Han DH; Park YN
Hepatol Int; 2020 Mar; 14(2):239-248. PubMed ID: 31993941
[TBL] [Abstract][Full Text] [Related]
19. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.
Na DC; Lee JE; Yoo JE; Oh BK; Choi GH; Park YN
Exp Mol Pathol; 2011 Feb; 90(1):66-73. PubMed ID: 20969862
[TBL] [Abstract][Full Text] [Related]
20. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]